Most bought healthcare stocks in Q1 2023
See which Healthcare stocks institutional investors increased the most in Q1 2023, measured as net growth in reported share positions from Q4 2022 into Q1 2023. Notable additions at the top of this list include GE HEALTHCARE TECHNOLOGY (GEHC), HALEON PLC-ADR (HLN), PFIZER INC (PFE), PRECIGEN INC (PGEN). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GEHC | GE HEALTHCARE TECHNOLOGY | 21,953,290 | $1.80B | 14 | 0 | 0 | 0 | 14 |
| HLN | HALEON PLC-ADR | 15,729,374 | $139.47M | 1 | 5 | 2 | 1 | 9 |
| PFE | PFIZER INC | 12,755,335 | -$159.71M | 1 | 10 | 7 | 0 | 19 |
| PGEN | PRECIGEN INC | 10,961,369 | $10.08M | 1 | 1 | 0 | 0 | 2 |
| AVTR | AVANTOR INC | 7,333,883 | $87.98M | 3 | 5 | 0 | 1 | 9 |
| CERS | CERUS CORP | 6,636,235 | $7.74M | 0 | 2 | 0 | 0 | 2 |
| BAX | BAXTER INTERNATIONAL INC | 4,230,348 | $76.40M | 3 | 4 | 3 | 0 | 12 |
| NKTR | NEKTAR THERAPEUTICS | 2,886,585 | -$46.23K | 0 | 1 | 0 | 0 | 2 |
| GSK | GSK PLC-SPON ADR | 2,688,238 | $199.60M | 1 | 4 | 5 | 0 | 11 |
| ARDX | ARDELYX INC | 2,688,000 | $13.75K | 0 | 1 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 2,509,122 | $84.84M | 1 | 2 | 4 | 0 | 7 |
| CVS | CVS HEALTH CORP | 2,480,493 | -$271.71M | 1 | 12 | 3 | 1 | 17 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,451,050 | $2.95K | 1 | 2 | 0 | 0 | 3 |
| ELAN | ELANCO ANIMAL HEALTH INC | 2,072,542 | -$238.37M | 0 | 2 | 2 | 0 | 5 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 2,061,998 | $111.26M | 0 | 1 | 0 | 0 | 2 |
| CTLT | CATALENT INC | 2,061,119 | $177.35M | 2 | 2 | 2 | 1 | 6 |
| VKTX | VIKING THERAPEUTICS INC | 1,765,663 | $32.56M | 1 | 0 | 1 | 0 | 2 |
| ALHC | ALIGNMENT HEALTHCARE INC | 1,763,712 | -$9.89M | 0 | 2 | 0 | 0 | 2 |
| OPCH | OPTION CARE HEALTH INC | 1,628,727 | $36.39M | 2 | 1 | 0 | 0 | 3 |
| ASRT | ASSERTIO HOLDINGS INC | 1,357,279 | $2.53M | 0 | 2 | 0 | 0 | 2 |
| CNC | CENTENE CORP | 1,231,746 | $34.77M | 1 | 2 | 2 | 1 | 5 |
| CMPS | COMPASS PATHWAYS PLC | 1,146,495 | $15.34M | 0 | 1 | 2 | 0 | 3 |
| BHC | BAUSCH HEALTH COS INC | 1,136,203 | $1.50M | 1 | 1 | 1 | 0 | 5 |
| DHR | DANAHER CORP | 1,117,519 | -$82.44M | 0 | 8 | 6 | 0 | 18 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,113,299 | -$965 | 0 | 1 | 0 | 0 | 1 |
| ERAS | ERASCA INC | 1,103,115 | $2.86K | 0 | 1 | 0 | 0 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1,037,158 | $23.54K | 1 | 1 | 0 | 0 | 2 |
| MRK | MERCK & CO. INC. | 1,024,428 | -$21.52M | 1 | 7 | 9 | 0 | 22 |
| BMY | BRISTOL-MYERS SQUIBB CO | 996,791 | -$28.11M | 3 | 4 | 9 | 4 | 19 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | 985,147 | $2.23K | 0 | 1 | 0 | 0 | 1 |
| CDNA | CAREDX INC | 944,149 | -$6.78M | 0 | 3 | 0 | 0 | 3 |
| ME | 23ANDME HOLDING CO -CLASS A | 890,909 | -$48.80K | 0 | 1 | 0 | 1 | 1 |
| OCGN | OCUGEN INC | 858,325 | -$381 | 0 | 1 | 0 | 1 | 1 |
| HRTX | HERON THERAPEUTICS INC | 814,336 | $907 | 0 | 1 | 0 | 0 | 1 |
| CDXS | CODEXIS INC | 802,701 | -$584.24K | 0 | 2 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 794,894 | -$181.02M | 0 | 2 | 3 | 1 | 5 |
| THC | TENET HEALTHCARE CORP | 765,585 | $54.00M | 0 | 2 | 1 | 0 | 3 |
| NVAX | NOVAVAX INC | 714,418 | -$379.27K | 0 | 3 | 0 | 1 | 3 |
| CMRX | CHIMERIX INC | 708,976 | $499 | 0 | 1 | 0 | 0 | 1 |
| RXRX | RECURSION PHARMACEUTICALS-A | 699,033 | -$38.12K | 0 | 2 | 0 | 0 | 2 |
| ABCL | ABCELLERA BIOLOGICS INC | 689,100 | -$301 | 0 | 1 | 0 | 0 | 1 |
| MRSN | MERSANA THERAPEUTICS INC | 678,800 | $1.79K | 0 | 1 | 0 | 0 | 1 |
| KZR | KEZAR LIFE SCIENCES INC | 612,584 | $1.59K | 0 | 1 | 0 | 0 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 551,300 | $14.72K | 0 | 1 | 0 | 0 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 546,400 | $2.22K | 0 | 1 | 0 | 0 | 1 |
| EWTX | EDGEWISE THERAPEUTICS INC | 519,200 | -$6.67M | 0 | 2 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 478,257 | -$51.29M | 0 | 1 | 0 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 475,664 | $1.77M | 0 | 2 | 1 | 0 | 3 |
| ACCD | ACCOLADE INC | 472,432 | $40.02M | 0 | 3 | 0 | 0 | 3 |
| VERU | VERU INC | 461,997 | $190 | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2023
What are the most bought Healthcare stocks in Q1 2023?
The most bought healthcare stocks in Q1 2023 are those with the largest increase in reported share counts across institutional investors compared to Q4 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2023?
Among filers in this sector, net additions were largest in companies such as GE HEALTHCARE TECHNOLOGY (GEHC), HALEON PLC-ADR (HLN), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.